Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.140
+0.010 (0.47%)
At close: Feb 11, 2026, 4:00 PM EST
2.170
+0.030 (1.40%)
After-hours: Feb 11, 2026, 4:04 PM EST
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $4.9 million as of February 11, 2026. Its market cap has decreased by -20.92% in one year.
Market Cap
4.90M
Enterprise Value
781.26K
1-Year Change
-20.92%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $4.90M, a decrease of -89.72%. That is a compound annual growth rate of -21.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 4.90M | -2.00% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 5.47M |
| 60 Degrees Pharmaceuticals | 5.29M |
| Processa Pharmaceuticals | 5.12M |
| Genprex | 5.10M |
| VivoSim Labs | 5.09M |
| Acurx Pharmaceuticals | 5.02M |
| Bio Green Med Solution | 4.95M |
| Decoy Therapeutics | 4.92M |